One-Month Dual Antiplatelet Therapy Followed by P2Y₁₂ Inhibitor Monotherapy After Biodegradable Polymer Drug-Eluting Stent Implantation ― The REIWA Region-Wide Registry ―

Masaru Ishida; Ryutaro Shimada; Fumiaki Takahashi; Masanobu Niiyama; Takenori Ishisone; Yuki Matsumoto; Yuya Taguchi; Takuya Osaki; Osamu Nishiyama; Hiroshi Endô; Ryohei Sakamoto; Kentaro Tanaka; Yorihiko Koeda; Takumi Kimura; Iwao Goto; Ryo Ninomiya; Wataru Sasaki; Tomonori Itoh; Yoshihiro Morino

doi:10.1253/circj.cj-24-0091

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Background: The safety and feasibility of using 1-month dual antiplatelet therapy (DAPT) followed by P2Y12inhibitor monotherapy for patients after percutaneous coronary intervention (PCI) with thin-strut biodegradable polymer drug-eluting stents (BP-DES) in daily clinical practice remain uncertain.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ishida et al. (2024) studied this question.

synapsesocial.com/papers/68e708c9b6db6435876824a4 https://doi.org/10.1253/circj.cj-24-0091

View Full Paper

Ask AI

Bookmark

Share

One-Month Dual Antiplatelet Therapy Followed by P2Y₁₂ Inhibitor Monotherapy After Biodegradable Polymer Drug-Eluting Stent Implantation ― The REIWA Region-Wide Registry ―

Ask about this paper

Abstract

Discussion

Cite This Study

One-Month Dual Antiplatelet Therapy Followed by P2Y₁₂ Inhibitor Monotherapy After Biodegradable Polymer Drug-Eluting Stent Implantation ― The REIWA Region-Wide Registry ―

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading